Production of Recombinant Cataract-Inducing Alpha-B Crystallin With E. coli
ISEF · 2023 Biomedical and Health Sciences
Overview
Congenital cataracts are present in 20,000-40,000 births each year and are among the leading causes of childhood blindness. Surgery is currently the only available treatment due to a poor understanding of the biochemical relationship between genetic mutation and cataract formation. Missense mutations in the eye lens crystallin alpha-B (CRYAB) have previously been shown to lower CRYAB's ability to "chaperone" the stability of the eye lens. This allows denatured proteins to aggregate and form cataracts. Cook et al. trained a machine learning (ML) model on bioinformatic data of documented CRYAB mutations to predict potentially pathogenic undocumented mutations. This tool has demonstrated up to 96.50% accuracy but must be experimentally validated in-vitro due to the poorly-understood prediction mechanisms of such an algorithm. This project investigates several ML-predicted mutations via recombinant DNA and measures their in-vitro pathogenic characteristics in comparison to documented control mutations. Wild-type CRYAB DNA were amplified by polymerase chain reaction and the 24 mutant DNA were obtained via site-directed mutagenesis. Proteins were expressed in E. coli and purified via ammonium sulfate precipitation and anion exchange chromatography. Characterization methods were selected to reflect the CRYAB pathogenic pathway. Cytotoxicity was measured by yield and purity, which were obtained by UV-vis and SDS-PAGE. The protein aggregation response to heat-shock and addition of Zn2+ was measured by dynamic light scattering. Chaperone activity was measured by tubulin aggregation assays. Current results have neither refuted nor validated the ML model with statistical significance but ongoing work holds promise for revealing the pathogenic mechanism of congenital cataracts.
Competition history
- ISEF 2023
Resources
Related projects
ISEF · 2023
Investigating Gamma S Crystallin Degradation in Normal and Cataract Lenses
ISEF · 2025
A Newly Identified Chromatin Remodeling Pathway in the Lens Enables a Proof-of-Concept Gene Therapy for Posterior Capsule Opacification
ISEF · 2024
Sorry, I Didn't See You: Testing the Effects of Photosensitive Medications on Crystallin Alpha to Study the Development of Cataracts
ISEF · 2025
Designing Enhanced DNAJB6 Variants: A New Approach to Prevent Alzheimer's Disease by Inhibiting Amyloid-beta 42 Clumping
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair